SCHEMBL3634587

SCHEMBL3634587

CCC(COCC1(CC)COC1)COCC1(CC)COC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14065277 0.95
SCHEMBL124322 0.87 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL17818692 0.85 CTSK (0.31)
SCHEMBL19105133 0.84 ALDH1A1 (0.43) ALDH1A1TSHR
SCHEMBL7746437 0.84 TSHR (0.32) TSHR
SCHEMBL6765811 0.82 TSHR (0.31) TSHR
SCHEMBL14256290 0.82 TSHR (0.31) TSHR
SCHEMBL12702640 0.81 TSHR (0.32) TSHR
SCHEMBL439901 0.81 TSHR (0.36) TSHR
SCHEMBL12447857 0.81 PRKD3 (0.31) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115700411-A Photosensitive composition, optical filter, image display device, and solid-state imaging element 东洋油墨SC控股株式会社 2023-02-07 CN disclosed
CN-113264856-B Sulfonium salt, photoacid generator, and photosensitive composition 东京应化工业株式会社 2022-11-22 CN disclosed
US-10431825-B2 Negative electrode for secondary battery, method for manufacturing same, and secondary battery using same NEC CORPORATION (JP) 2019-10-01 US disclosed
CN-110225933-A Aqueous polyurethane resin combination 株式会社艾迪科 2019-09-10 CN disclosed
CN-109312055-A Curable composition, method for producing cured product, and cured product thereof 株式会社ADEKA 2019-02-05 CN disclosed
US-20160172677-A1 NEGATIVE ELECTRODE FOR SECONDARY BATTERY, METHOD FOR MANUFACTURING SAME, AND SECONDARY BATTERY USING SAME NEC CORPORATION (JP) 2016-06-16 US disclosed
EP-2760894-A1 PHOTO-CURABLE COMPOSITION AND PATTERNING METHOD USING THE SAME Canon Kabushiki Kaisha (JP) 2014-08-06 EP disclosed
WO-2013069511-A1 PHOTO-CURABLE COMPOSITION AND PATTERNING METHOD USING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-05-16 WO disclosed
WO-2012106589-A2 SOLAR CELL ELECTRODE, AND METHOD FOR MANUFACTURING THE SAME, AND PASTE FOR THE SOLAR CELL ELECTRODE E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-08-09 WO disclosed
EP-2160649-A1 CLEAR AND COLORLESS THREE-DIMENSIONAL ARTICLES MADE VIA STEREOLITHOGRAPHY AND METHOD OF MAKING SAID ARTICLES DSM IP Assets B.V. (NL) 2010-03-10 EP disclosed
WO-2009005576-A1 CLEAR AND COLORLESS THREE-DIMENSIONAL ARTICLES MADE VIA STEREOLITHOGRAPHY AND METHOD OF MAKING SAID ARTICLES DSM IP ASSETS B.V. (NL) 2009-01-08 WO disclosed
EP-1171502-A1 RESIN COMPOSITION FOR PHOTOFABRICATION OF THREE DIMENSIONAL OBJECTS DSM N.V. (NL) 2002-01-16 EP disclosed
WO-2000063272-A1 RESIN COMPOSITION FOR PHOTOFABRICATION OF THREE DIMENSIONAL OBJECTS DSM N.V. (NL) 2000-10-26 WO disclosed
WO-2000049080-A1 PHOTO CURABLE LIQUID RESIN COMPOSITION AND PHOTOFABRICATED CURED PRODUCT DSM N.V. (NL) 2000-08-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10431825-B2 Negative electrode for secondary battery, method for manufacturing same, and secondary battery using same CACNA2D3, CACNA2D2, CACNA2D1 ALDH1A1 2091/4885TSHR 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.